Dietary supplementation with fresh pineapple juice decreases inflammation and colonic neoplasia in IL-10-deficient mice with colitis

Inflammatory Bowel Diseases

Volumn 16, Issue 12, 2010, Pages 2012-2021

  Hale, Laura P ^a   Chichlowski, MacIej ^a   Trinh, Chau T ^a   Greer, Paula K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

bromelain; chemoprevention; IBD; therapy

Indexed keywords

BROMELAIN; INTERLEUKIN 10; PIROXICAM; PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL MOUSE; CELL SURFACE; COLITIS; COLON TUMOR; COMPARATIVE STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LONG TERM CARE; MALE; MORBIDITY; MOUSE; NONHUMAN; PINEAPPLE JUICE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SPLEEN CELL; SURVIVAL;

ADMINISTRATION, ORAL; ANANAS; ANIMALS; BROMELAINS; COLITIS; COLONIC NEOPLASMS; CYTOKINES; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FEMALE; INTERLEUKIN-10; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHYTOTHERAPY;

EID: 78649586401     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21320     Document Type: Article

References (28)

1. Rowan AD, Buttle DJ, Barrett AJ,. The cysteine proteinases of the pineapple plant. Biochem J. 1990; 266: 869-875.
2. Hale LP, Singer KH, Haynes BF,. CD44 antibody against In(Lu)-related p80, lymphocyte homing receptor molecule, inhibits the binding of human erythrocytes to T cells. J Immunol. 1989; 143: 3944-3948.
3. Hale LP, Haynes BF,. Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol. 1992; 149: 3809-3816.
4. Hale LP, Greer PK, Sempowski GD,. Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation. Clin Immunol. 2002; 104: 183-190.
5. Hale LP, Greer PK, Trinh CT, et al. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease. Clin Immunol. 2005; 116: 135-142.
6. Kane S, Goldberg MJ,. Use of bromelain for mild ulcerative colitis. Ann Int Med. 2000; 132: 680.
7. Onken JE, Greer PK, Calingaert B, et al. Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro. Clin Immunol. 2008; 126: 345-352.
8. Fitzhugh DJ, Shan S, Dewhirst MW, et al. Bromelain treatment decreases neutrophil migration to sites of inflammation. Clin Immunol. 2008; 128: 66-74.
9. Barrett AJ, Rawlings ND, Woessner JF, (eds.). Handbook of proteolytic enzymes. San Diego: Academic Press; 1998: 566-567.
10. Yamada F, Takahashi N, Murachi T,. Purification and characterization of a proteinase from pineapple fruit, fruit bromelain FA2. J Biochem. 1976; 79: 1223-1234.
11. Berg DJ, Zhang J, Weinstock JV, et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology. 2002; 123: 1527-1542.
12. Chichlowski M, Sharp JM, Vanderford DA, et al. Helicobacter typhlonius and H. rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL-10-deficient mice. Comp Med. 2008; 58: 534-541.
13. American Veterinary Medical Association. AVMA guidelines on euthanasia: June 2007 update. Available at: Accessed May 6. 2009.
14. Hale LP, Greer PK, Trinh CT, et al. Proteinase activity and stability of natural bromelain preparations. Int Immunopharmacol. 2005; 5: 783-793.
15. Hale LP,. Proteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of mice. Int Immunopharmacol. 2004; 4: 255-264.
16. Boivin GP, Washington K, Yang K, et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology. 2003; 124: 762-777.
17. Hale LP, Fitzhugh, DJ, Staats HF,. Oral immunogenicity of the plant proteinase bromelain. Int Immunopharmacol. 2006; 6: 2038-2046.
18. -/- mice. Helicobacter. 2007; 12: 598-604.
19. Mynott TL, Ladhams A, Scarmato P, et al. Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cells. J Immunol. 1999; 163: 2568-2575.
20. Mynott TL, Crossett B, Prathalingam SR,. Proteolytic inhibition of Salmonella enterica serovar Typhimurium-induced activation of the MAP kinases ERK and JNK in cultured human intestinal cells. Infect Immun. 2002; 70: 86-95.
21. Kleef R, Delohery TM, Bovbjerg DH,. Selective modulation of cell adhesion molecules on lymphocytes by bromelain protease 5. Pathobiology. 1996; 64: 339-346.
22. Konig R,. Interactions between MHC molecules and co-receptors of the TCR. Curr Opin Immunol. 2002; 14: 75-83.
23. Leishman AJ, Naidenko OV, Attinger A, et al. T cell responses modulated through interactions between CD8αα and the nonclassical MHC molecule, TL. Science. 2001; 294: 1936-1939.
24. Alexander DR,. The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function. Semin Immunol. 2000; 12: 349-359.
25. Protin U, Schweighoffer T, Jochum W, et al. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J Immunol. 1999; 163: 4917-4923.
26. Steeber D, Tedder T,. Adhesion molecule cascades direct lymphocyte recirculation and leukocyte migration during inflammation. Immunol Res. 2000; 22: 299-317.
27. Munzig E, Eckert K, Harrach T, et al. Bromelain protease F9 reduces the CD44 mediated adhesion of human peripheral blood lymphocytes to human umbilical vein endothelial cells. FEBS Lett. 1994; 351: 215-218.
28. Denning SM, Le PT, Singer KH, et al. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol. 1990; 144: 7-15.